<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The physiological infrarenal aortic diameter varies between 12.4 mm in women an 27.6 mm in men </plain></SENT>
<SENT sid="1" pm="."><plain>As defined, an aneurysmatic <z:mpath ids='MPATH_66'>dilatation</z:mpath> begins with 29 mm </plain></SENT>
<SENT sid="2" pm="."><plain>According to that, 9% of <z:hpo ids='HP_0000001'>all</z:hpo> people above the age of 65 are affected by an <z:hpo ids='HP_0004953'>abdominal aortic aneurysm</z:hpo> (AAA) </plain></SENT>
<SENT sid="3" pm="."><plain>Compared with the female sex, the male sex predominates at a rate of about 5:1 </plain></SENT>
<SENT sid="4" pm="."><plain>The disease is predominant in men of the white race </plain></SENT>
<SENT sid="5" pm="."><plain>In black men, black and white women the incidence of AAA is identical </plain></SENT>
<SENT sid="6" pm="."><plain>38 to 50 percent of the AAA patients (patients) suffer from <z:hpo ids='HP_0000822'>hypertension</z:hpo>, 33 to 60% from coronary, 28% from cerebrovascular and 25% from <z:e sem="disease" ids="C1167668" disease_type="Disease or Syndrome" abbrv="">peripheral occlusive disease</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The AAA expansion rate varies between 0.2 and 0.8 cm per year and is exponential from a diameter of 5 cm on </plain></SENT>
<SENT sid="8" pm="."><plain>In autopsy studies, the rupture rates with AAA diameters of &lt; 5 cm, between 5.1 and 6.9 cm, and of &gt; 7 cm were below 5%, 39% and 65%, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>70% of the AAA patients do not die of a rupture, but of a <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Serum markers, such as metalloproteinases and procollagen <z:chebi fb="7" ids="16670">peptides</z:chebi> are significantly increased in AAA patients </plain></SENT>
<SENT sid="11" pm="."><plain>Thoraco-abdominal <z:hpo ids='HP_0002617'>aneurysms</z:hpo> (<z:chebi fb="2" ids="32497">TAA</z:chebi>) make up only 2 to 5% of <z:hpo ids='HP_0000001'>all</z:hpo> degenerative <z:hpo ids='HP_0002617'>aneurysms</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>20 to 30% of the <z:chebi fb="2" ids="32497">TAA</z:chebi> patients are also affected by an AAA </plain></SENT>
<SENT sid="13" pm="."><plain>80% of the <z:chebi fb="2" ids="32497">TAA</z:chebi> are degenerative, 15 to 20% are a consequence of the <z:hpo ids='HP_0011010'>chronic</z:hpo> dissection--including 5% of Marfan patients--, 2% occur in case of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> and 1 to 2% in case of <z:mp ids='MP_0010139'>aortitis</z:mp> </plain></SENT>
<SENT sid="14" pm="."><plain>The <z:chebi fb="2" ids="32497">TAA</z:chebi> incidence in 100,000 person-years is 5.9% during a monitoring period of 30 years </plain></SENT>
<SENT sid="15" pm="."><plain>In case of <z:chebi fb="2" ids="32497">TAA</z:chebi>, an operation is indicated with a maximum diameter of 5.5 to 6 cm and more and, in case of a <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e> (incidence of 1:10,000), with a maximum diameter of 5.5 cm and more </plain></SENT>
<SENT sid="16" pm="."><plain>With regard to aorto-iliac occlusive diseases, there are defined 3 types of distribution </plain></SENT>
<SENT sid="17" pm="."><plain>Type I refers to the region of the bifurcation itself </plain></SENT>
<SENT sid="18" pm="."><plain>Type II defines the diffuse aorto-iliac spread of the disease </plain></SENT>
<SENT sid="19" pm="."><plain>Type III designates multiple-level occlusions also beyond the inguinal ligament </plain></SENT>
<SENT sid="20" pm="."><plain>Type I patients in most cases are female and more frequently suffer from <z:e sem="disease" ids="C0020473" disease_type="Disease or Syndrome" abbrv="">hyperlipidaemia</z:e>, while Type II patients are affected by <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="21" pm="."><plain>Compared to Type II patients, Type I patients have a life expectancy that is 10 years higher </plain></SENT>
<SENT sid="22" pm="."><plain>Type I and Type II patients often suffer from a pelvic <z:e sem="disease" ids="C1456822" disease_type="Disease or Syndrome" abbrv="">claudication</z:e> and, unlike Type III patients, are more frequently affected by arterio-arterial embolisms </plain></SENT>
</text></document>